jak2q | 20760
JAK2 p.V617F Mutation course (quantitative)
Keywords:
Essential thrombocythemia
Essential thrombocytosis
Essential thrombocytosis
Leukocytosis
MPN
Myeloproliferation
Myeloproliferative Neoplasm
Polycythaemia vera
Polycythemia
Polycythemia
Polyglobulia
Primary myelofibrosis
Status
| Material |
|
||
|---|---|---|---|
| Hint |
There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. | Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent). |
||
| Min. volume | 4 mL | ||
| Stability |
Stability
1 day / 18-25°C; 4 days / 2-8°C
|
||
| Duration | 5 days | ||
| Frequency | 2 x per week | ||
| Method | Next Generation Sequencing |
Price/Rate
| Price |
Price
CHF 470.60
|
|---|---|
| Rate |
Rate
470.60 TP
|
| AL Position | 37.0540 |
| Histopathologie/Zytopathologie, nichtärz |
Reference values
| Value and unit | Age and unit | Sex |
|---|---|---|
| < 1 | f+m |
